Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PASITHEA THERAPEUTICS CORP.

(KTTA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Pasithea Therapeutics : Partners With Evotec for Drug Development Project

10/11/2021 | 10:53am EST


© MT Newswires 2021
All news about PASITHEA THERAPEUTICS CORP.
08:02aPasithea Therapeutics Expands its Mobile Clinics into Florida and Nevada
AQ
11/29PASITHEA THERAPEUTICS : Announces Pricing of a $30.4 Million Private Placement Priced At a..
PU
11/29Pasithea Therapeutics Corp. Announces Closing of $30.4 Million Private Placement Priced..
GL
11/29PASITHEA THERAPEUTICS CORP. : Entry into a Material Definitive Agreement, Unregistered Sal..
AQ
11/29Pasithea Therapeutics Corp. announced that it has received $30.38 million in funding
CI
11/24Top Midday Decliners
MT
11/24Pasithea Therapeutics Corp. Announces Pricing of a $30.4 Million Private Placement Pric..
GL
11/24Pasithea Therapeutics Corp. announced that it expects to receive $30.38 million in fund..
CI
11/23Health Care Stocks Nudging Back Onto Positive Ground
MT
11/23Health Care Stocks Partially Recover From Morning Slide
MT
More news
Financials (USD)
Sales 2021 0,10 M - -
Net income 2021 - - -
Net cash 2021 0,24 M - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 47,7 M 47,7 M -
EV / Sales 2021 474x
EV / Sales 2022 9,26x
Nbr of Employees 2
Free-Float 42,1%
Chart PASITHEA THERAPEUTICS CORP.
Duration : Period :
Pasithea Therapeutics Corp. Technical Analysis Chart | KTTA | US70261F1030 | MarketScreener
Technical analysis trends PASITHEA THERAPEUTICS CORP.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 3,61 $
Average target price 4,73 $
Spread / Average Target 31,0%
Managers and Directors
Tiago Reis Marques Chief Executive Officer & Director
Stanley M. Gloss Chief Financial Officer
Israel Maxx Abramowitz Co-Chief Operating Officer & Director
Yassine Bendiabdallah Co-Chief Operating Officer & Director
Craig Auringer Director
Sector and Competitors
1st jan.Capi. (M$)
PASITHEA THERAPEUTICS CORP.0.00%48
MODERNA, INC.237.35%142 893
LONZA GROUP AG30.63%59 859
IQVIA HOLDINGS INC.44.63%49 504
SEAGEN INC.-8.64%29 257
CELLTRION, INC.-42.34%23 827